Online citations, reference lists, and bibliographies.
← Back to Search

Clinical Applications Of Optical And Optoacoustic Imaging Techniques In The Breast

W. Yang
Published 2018 · Computer Science, Engineering

Save to my Library
Download PDF
Analyze on Scholarcy
Share
Exploitation of the optical properties of tissue to characterize biologic composition has created an era of continuous growth over the past decades for optical imaging. These changes enable the identification of functional abnormalities in conjunction with structural changes of biologic tissue. There is currently a wide array of technologies and applications in development and clinical use. The range of different optical hardware choices has led to systems that utilize optical tissue contrast to address specific clinical needs.
This paper references
Breast cancer detection based on incremental biochemical and physiological properties of breast cancers: a six-year, two-site study.
B. Chance (2005)
10.1117/1.2337546
In vivo absorption, scattering, and physiologic properties of 58 malignant breast tumors determined by broadband diffuse optical spectroscopy.
A. Cerussi (2006)
10.1148/radiol.2015150013
Neoadjuvant Chemotherapy for Breast Cancer: Functional Tumor Volume by MR Imaging Predicts Recurrence-free Survival-Results from the ACRIN 6657/CALGB 150007 I-SPY 1 TRIAL.
N. Hylton (2016)
10.1002/cncr.27995
Magnetic resonance imaging as a predictor of pathologic response in patients treated with neoadjuvant systemic treatment for operable breast cancer
J. F. De Los Santos (2013)
10.1148/radiol.14132641
Radiogenomic analysis of breast cancer: luminal B molecular subtype is associated with enhancement dynamics at MR imaging.
M. Mazurowski (2014)
10.1117/12.2318802
Full-view 3D imaging system for functional and anatomical screening of the breast
A. Oraevsky (2018)
10.1002/jmri.24890
Breast cancer subtype intertumor heterogeneity: MRI‐based features predict results of a genomic assay
E. Sutton (2015)
10.2463/MRMS.2012-0095
Correlations between apparent diffusion coefficient values and prognostic factors of breast cancer.
T. Kamitani (2013)
10.1007/s00330-004-2246-z
Locally advanced breast cancer: comparison of mammography, sonography and MR imaging in evaluation of residual disease in women receiving neoadjuvant chemotherapy
V. Londero (2004)
10.1093/jnci/djs528
Meta-analysis of magnetic resonance imaging in detecting residual breast cancer after neoadjuvant therapy.
M. L. Marinovich (2013)
10.1148/RADIOL.2016152331
Pretreatment MR Imaging Features of Triple-Negative Breast Cancer: Association with Response to Neoadjuvant Chemotherapy and Recurrence-Free Survival.
M. Bae (2016)
10.1148/radiol.2017172228
A Pivotal Study of Optoacoustic Imaging to Diagnose Benign and Malignant Breast Masses: A New Evaluation Tool for Radiologists.
E. Neuschler (2018)
10.1158/0008-5472.CAN-16-0346
Predicting Responses to Neoadjuvant Chemotherapy in Breast Cancer: ACRIN 6691 Trial of Diffuse Optical Spectroscopic Imaging.
B. Tromberg (2016)
10.1002/jmri.21884
Diffusion‐weighted imaging of breast cancer: Correlation of the apparent diffusion coefficient value with prognostic factors
S. Kim (2009)
10.1201/b17321
Biomedical Photonics Handbook, 3 Volume Set
T. Vo-Dinh (2014)
10.1097/RCT.0b013e318246abf3
Magnetic Resonance Imaging Patterns of Tumor Regression After Neoadjuvant Chemotherapy in Breast Cancer Patients: Correlation With Pathological Response Grading System Based on Tumor Cellularity
T. Kim (2012)
10.1007/s10434-001-0549-8
MRI Phenotype Is Associated With Response to Doxorubicin and Cyclophosphamide Neoadjuvant Chemotherapy in Stage III Breast Cancer
L. Esserman (2001)
10.1148/radiol.10092021
Diffusion-weighted MR imaging: pretreatment prediction of response to neoadjuvant chemotherapy in patients with breast cancer.
S. Park (2010)
Diffusion-weighted MR imaging: pretreatment prediction of response to neoadjuvant chemotherapy in patients with breast
S. H. Park (2010)
10.1002/jmri.23971
Texture analysis in assessment and prediction of chemotherapy response in breast cancer
A. Ahmed (2013)
10.1002/jmri.25479
Diffusion‐weighted breast MRI: Clinical applications and emerging techniques
S. Partridge (2017)
10.1186/1471-2407-10-693
Meta-analysis of quantitative diffusion-weighted MR imaging in the differential diagnosis of breast lesions
X. Chen (2010)
10.1117/12.2209398
Advanced laser system for 3D optoacoustic tomography of the breast
M. Klosner (2016)
10.1088/0031-9155/57/17/5399
Investigation of iterative image reconstruction in three-dimensional optoacoustic tomography.
K. Wang (2012)
10.1155/2012/863747
Optical Imaging in Breast Cancer Diagnosis: The Next Evolution
M. Herranz (2012)
I-SPY 1 TRIAL and ACRIN
R. A. Mukhtar (2013)
10.1245/s10434-013-3038-y
Clinically Meaningful Tumor Reduction Rates Vary by Prechemotherapy MRI Phenotype and Tumor Subtype in the I-SPY 1 TRIAL (CALGB 150007/150012; ACRIN 6657)
R. Mukhtar (2013)
10.1515/raon-2016-0007
Diagnostic accuracy of MRI to evaluate tumour response and residual tumour size after neoadjuvant chemotherapy in breast cancer patients
Alberto Bouzón (2016)



Semantic Scholar Logo Some data provided by SemanticScholar